Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link

Disclaimer: Early release articles are not considered as final versions. Any changes will be reflected in the online version in the month the article is officially released.

Volume 31, Number 3—March 2025
Research Letter

Evaluation of High-Dose Isoniazid in Multidrug-Resistant Tuberculosis Treatment

Valentina GerussiComments to Author , Tania Petersen, Isabelle Bonnet, Alexandra Aubry, Marwa Bachir, Esther Gyde, Florence Morel, Corentin Poignon, Brigitte Rached, Valérie Pourcher, Christophe Rioux, Dorothée Vallois, Nicolas Veziris, Jérôme Robert, and Lorenzo Guglielmetti
Author affiliation: Università degli Studi di Trieste, Trieste, Italy (V. Gerussi); Sorbonne Université, Centre National de Référence des Mycobactéries et de la Résistance des Mycobactéries aux Antituberculeux, Assistance Publique–Hôpitaux de Paris, Paris, France (T. Petersen, I. Bonnet, A. Aubry, E. Gyde, F. Morel, C. Poignon, B. Rached, V. Pourcher, N. Veziris, J. Robert, L. Guglielmetti); Centre Hospitalier de Saint-Denis-Centre Hospitalier de Gonesse, Saint-Denis, France (M. Bachir); Université Paris Cité, Paris (C. Rioux, D. Vallois)

Main Article

Figure

Flowchart of MDR TB isolates identified in France during 2008–2022 included in an evaluation of high-dose isoniazid in MDR TB treatment. DST, drug susceptibility testing; MDR TB, multidrug-resistant tuberculosis; SCR, short-course regimen.

Figure. Flowchart of MDR TB isolates identified in France during 2008–2022 included in an evaluation of high-dose isoniazid in MDR TB treatment. DST, drug susceptibility testing; MDR TB, multidrug-resistant tuberculosis; SCR, short-course regimen.

Main Article

Page created: January 07, 2025
Page updated: February 21, 2025
Page reviewed: February 21, 2025
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external